Lexology November 4, 2025
McDermott Will & Schulte LLP

European life sciences businesses have been closely tracking geopolitics and global policy changes over the past 12 months, particularly as the new administration in the United States heightens its focus on drug pricing.

Against this backdrop, hundreds of healthcare professionals, investors, and industry changemakers gathered in London for McDermott Will & Schulte’s annual HPE Europe conference, held September 25, 2025. Our keynote speakers, hosts of the hit UK podcast The Rest is Money Steph McGovern and Robert Peston, outlined macro trends impacting the markets, kicking off lively discussions about private equity investment in European life sciences and the opportunities on offer today and leading into 2026.

In Depth

The current policy environment featured heavily in these discussions. The US accounts...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Investments, Pharma, Pharma / Biotech, Trends
What’s new with GLP-1s
Navigating the Shift: 2026 Medicare Drug Pricing and the Future of Pharmacy
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
283: A candid conversation: Physicians on the front lines of GLP‑1 care
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model

Share Article